Ameristat Pharmaceuticals, Inc.   

Erbitux -


ERBITUX® (Cetuximab) in combination with radiation therapy, is indicated for the treatment of a certain type of locally or regionally advanced head and neck cancer.

ERBITUX alone is indicated for the treatment of patients with head and neck cancer whose tumor has grown larger or has spread to other parts of the body after receiving treatment containing a platinum-based chemotherapy.

ERBITUX is available by prescription only and administered intravenously.

More information is available at